DPYSL3 and prostate cancer: Moreover, treatment of C4-2 and LNCaP prostate cancer cells using an orthotopic xenograft tumor model in athymic mice with the aptamer-saRNA chimera revealed a significant suppression of distal metastasis, as well as enhanced DPYSL3 expression in xenograft tissues [109].